DI RESTA, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 429
EU - Europa 396
AS - Asia 99
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 3
Totale 935
Nazione #
US - Stati Uniti d'America 429
SE - Svezia 222
IT - Italia 98
CN - Cina 52
FI - Finlandia 32
SG - Singapore 32
DE - Germania 18
IE - Irlanda 9
GR - Grecia 7
IN - India 6
IR - Iran 6
GB - Regno Unito 5
CL - Cile 3
CM - Camerun 3
A1 - Anonimo 2
BE - Belgio 2
EU - Europa 2
PH - Filippine 2
FR - Francia 1
HU - Ungheria 1
PE - Perù 1
RU - Federazione Russa 1
TR - Turchia 1
Totale 935
Città #
Ashburn 95
Lawrence 57
Princeton 57
New York 52
Shanghai 40
Helsinki 30
Boardman 24
Milan 20
Singapore 18
Rome 14
Seattle 14
Dublin 9
Viareggio 5
Ardabil 4
Athens 4
Atlanta 4
Turin 4
Washington 4
Los Angeles 3
Lykovrysi 3
Manchester 3
Pune 3
Santiago 3
Antwerp 2
Bitonto 2
Cebu City 2
Chandler 2
Falkenstein 2
Indore 2
Lappeenranta 2
Las Vegas 2
Malandriano 2
Modena 2
Naples 2
Nerviano 2
Orta Nova 2
Pistoia 2
Sant'Ambrogio di Valpolicella 2
Seriate 2
Vaprio d'Adda 2
Varedo 2
Beijing 1
Bergamo 1
Borås 1
Budapest 1
Campodolcino 1
Cantù 1
Catania 1
Chennai 1
Cremona 1
Girasole 1
Izmir 1
Kish 1
Lima region 1
Macerata 1
Mairano 1
Monza 1
Palermo 1
Piacenza 1
Portland 1
Rockville 1
Shenzhen 1
Temple Hills 1
Zanjan 1
Totale 529
Nome #
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine 32
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests 31
Machine Learning based on laboratory medicine test results in diagnosis and prognosis for COVID-19 patients: A systematic review 29
Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy 26
Concealed Substrates in Brugada Syndrome: Isolated Channelopathy or Associated Cardiomyopathy? 25
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 25
A longitudinal analysis of humoral, T cellular response and influencing factors in a cohort of healthcare workers: Implications for personalized SARS-CoV-2 vaccination strategies 24
Electrophysiological properties of mutant alpha2beta4 nAChR linked to a form of Autosomal Dominant Nocturnal Frontal Lobe Epilepsy (ADNFLE) 24
Cardiac magneti resonance and arrhythmic risk stratification of cardiomyopathy associated with lamin A/C mutations: results from a 5 years study 24
Erratum: Genetic testing in neurology exploiting next generation sequencing: State of art (Neural Regeneration Research (2020) 15:2 (265-266) DOI: 10.4103/1673-5374.265554) 23
Analytical Ancestry: Evolution of the Array in Analysis 22
A Brugada Syndrome mutation (p.S216L) and its modulation by p.H558R polymorphism: standard and dynamic characterization 21
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects 20
Brugada syndrome genetics is associated with phenotype severity 19
Current Updates on Expanded Carrier Screening: New Insights in the Omics Era 18
Myocardial Inflammation as a Manifestation of Genetic Cardiomyopathies: From Bedside to the Bench 18
Effect of Carbamazepine and Related Compounds on Ligand-Gated Channels: Possible Implications for Synaptic Transmission and Side Effects. 18
Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects 18
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy 17
Challenges of the Effectiveness of Traumatic Brain Injuries Biomarkers in the Sports-Related Context 17
A novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmia 17
Current scenario of the genetic testing for rare neurological disorders exploiting next generation sequencing 17
Effect of carbamazepine and oxcarbazepine on wild-type and mutant neuronal nicotinic acetylcholine receptors linked to nocturnal frontal lobe epilepsy 16
Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation 16
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine 15
Exploratory assessment of serological tests to determine antibody titer against SARS-CoV-2: Appropriateness and limits 15
Alpha2-I279N human nicotinic acetylcholine receptors, linked to a form of nocturnal epilepsy, present higher sensitivity to agonists 15
Premature cardiac senescence in patients with lamin A/C mutations: at least 5 years gap from electrical to mechanical dysfunction 15
Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign 15
Genetic background of mitral valve prolapse 15
Molecular diagnostics in the prenatal age: technological evolution and ethical implications in reproductive medicine|La diagnostica molecolare in epoca prenatale: evoluzione tecnologica ed implicazioni etiche in medicina della riproduzione 15
Functional Characterisation of the Rare SCN5A p.E1225K Variant, Segregating in a Brugada Syndrome Familial Case, in Human Cardiomyocytes from Pluripotent Stem Cells 14
Exome sequencing and pathway analysis for identification of genetic variability relevant for bronchopulmonary dysplasia (BPD) in preterm newborns: A pilot study 14
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 14
The gender impact assessment among healthcare workers in the sars-cov-2 vaccination—an analysis of serological response and side effects 14
Health technology assessment to employ COVID-19 serological tests as companion diagnostics in the vaccination campaign against SARS-CoV-2 13
Genetic factors predisposing to bronchopulmonary dysplasia. A pilot study by exome sequencing and pathways analysis 13
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 13
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy 13
Electrocardiogram Changes in the Postictal Phase of Epileptic Seizure: Results from a Prospective Study 12
Increased sensitivity of the neuronal nicotinic receptor alpha2 subunit causes familial epilepsy with nocturnal wandering and ictal fear 12
P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study 12
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 12
Evaluation of three advanced methodologies, COLD-PCR, microarray and ddPCR, for identifying the mutational status by liquid biopsies in metastatic colorectal cancer patients 12
SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome 12
Evidence of significant difference in key covid-19 biomarkers during the italian lockdown strategy. A retrospective study on patients admitted to a hospital emergency department in northern italy 12
The total testing process harmonization: the case study of SARS-CoV-2 serological tests 11
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 11
High-throughput genetic characterization of a cohort of Brugada syndrome patients. 10
Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities 10
Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear 10
Editorial: Whole Genome Sequencing for rare diseases 9
Evaluation of damaging effects of splicing mutations: validation of an in vitro method for diagnostic laboratories 9
Implementation of companion diagnostics in the clinical laboratories: the BRAF example in Melanoma 9
Transcriptional role of androgen receptor in the expression of long non-coding RNA Sox2OT in neurogenesis 9
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe. 9
Generation of a triadin KnockOut syndrome zebrafish model 9
Advance in Genomics of Rare Genetic Diseases 8
Increased sensitivity of the alpha-2 neuronal nicotinic receptor causes familial epilepsy with nocturnal wandering and ictal fear 8
Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches 8
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 8
New molecular approaches to Alzheimer's disease 8
Genetic testing in neurology exploiting next generation sequencing: State of art 8
Next Generation Sequencing: From Research Area to Clinical Practice 8
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 7
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe 7
Translating genes into health. 7
Genetics can contribute to the prognosis of the Brugada syndrome: a pilot model for risk stratification. 6
Human neuronal nicotinic receptors and epilepsy during sleep 6
Personalized laboratory medicine: A patient-centered future approach 6
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 6
Updated clinical overview on cardiac laminopathies: an electrical and mechanical disease 5
Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey 5
Introduction to ion channels 4
null 4
Six months SARS-CoV-2 serology in a cohort of mRNA vaccinated subjects over 90 years old 3
Melanocortin-1 receptor (MC1R): a review for dermatologists 2
Totale 1.044
Categoria #
all - tutte 13.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 20 0 2 1 0 2 0 0 0 2 0 0
2020/202115 4 1 0 5 1 2 0 0 1 0 0 1
2021/202282 0 0 0 16 8 8 33 1 3 4 1 8
2022/2023434 133 85 37 0 14 57 13 29 16 2 25 23
2023/2024474 28 18 58 75 27 99 17 42 1 13 18 78
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.044